News

Vous pouvez consulter les dernières actualités, articles et annonces sur EndoPredict ci-dessous ou visiter notre page officielle des communiqués de presse de Myriad Genetics.

Regardez le symposium satellite industriel ESMO 2022 de Myriad Genetics

September 19, 2022

Devrions-nous utiliser les signatures génétiques pour les décisions quant au recours à une chimiothérapie chez les patientes préménopausées RE+/HER2- ?...

EndoPredict informs treatment decisions for premenopausal breast cancer

August 31, 2022

New publication shows EndoPredict Breast Cancer Prognostic Test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid ...

High adherence to EndoPredict test results in extended endocrine therapy decision making in early breast cancer

June 22, 2022

Clinicians demonstrated up to 100% adherence to EndoPredict test results in extended endocrine therapy decision making As a leader in genetic testing and pr...